A Study of Ramucirumab (LY3009806) Given by Injection Under the Skin in Participants With Advanced Cancer

Summary

The purpose of this study in participants with advanced cancer is to learn more about the safety of ramucirumab when given by injection under the skin (subcutaneous injection). The study will also measure how much ramucirumab gets into the bloodstream and how long it takes the body to get rid of it.

Timeline

Start

2021-02-23

Primary completion

2021-05-25

Completion

2021-05-25

Outcome

Outcome not reported

Stopped: “Study terminated due to inadequate PK profile associated with the subcutaneous formulation.”

Drugs

Indications